Effect of fast tract surgery on postoperative pulmonary complications of non-small cell lung cancer patients undergoing radical pulmonary lobectomy
10.3760/cma.j.issn.1008-1372.2011.01.011
- VernacularTitle:快速康复外科对非小细胞肺癌患者术后肺部并发症的影响
- Author:
Jinyi WANG
;
Guohan CHEN
;
Xuan HONG
;
Gang LIU
;
Qinchuan LI
;
Zhongmin LIU
- Publication Type:Journal Article
- Keywords:
Rehabilitation/MT;
Carcinoma,non-small-cell lung/RH/SU;
Postoperative complications;
Surgical procedures,operative/MT;
Lung diseases/CO
- From:
Journal of Chinese Physician
2011;13(1):38-40
- CountryChina
- Language:Chinese
-
Abstract:
Objective In a prospective randomized controlled pilot study, effects of postoperative pulmonary complications on a conservative treatment surgery (CTS) and fast track surgery (FTS) treatment regimen in non-small cell lung cancer (NSCLC) patients undergoing pulmonary lobectomy were compared.Methods Eighty patients who underwent radical pulmonary lobectomy surgical treatment for non-small cell lung cancer disease from January 2008 to May 2010 in our hospital were random assigned to either fast track surgery treatment (40 FTS group) or conservative treatment surgery regimen (40 CTS group). Study endpoints were pulmonary complications ( pneumonia, atelectasis, prolonged air leak ＞ 7 days); Further parameters assessed in the postoperative course of patients were the need for postoperative mechanical ventilation, temperature at the end of the operation, length of stay (LOS) on intensive care unit (ICU) and day of discharge. Results The rate of postoperative pulmonary complications was 34. 21% in CTS group and 8. 33% in FTS group ( P ＜0. 05). Median length of stay on ICU was comparable in both groups ( 1 day),but the day of discharge was significantly different in both groups [( 11. 1 ±3.6)d vs ( 16. 6 ±5.7)d, P ＜0. 01]. Conclusion Using this fast track clinical pathway, the rate of pulmonary complications could be significantly decreased as compared to a conservative treatment regimen. Our results supported the implementation of an optimized perioperative treatment in lung surgery for non-small cell lung cancer patients undergoing radical pulmonary in order to reduce pulmonary complications after major lung surgery.
